학술논문
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and CCNE1 amplified ovarian cancer
Document Type
Article
Author
Source
In: iScience . (iScience, 19 July 2024, 27(7))
Subject
Language
English
ISSN
25890042